These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 30785245)
1. Additional value of tau protein measurement in the diagnosis of Creutzfeldt-Jakob disease. Cseh EK; Veres G; Danics K; Szalárdy L; Nánási N; Klivényi P; Vécsei L; Zádori D Ideggyogy Sz; 2019 Jan; 72(1-2):39-47. PubMed ID: 30785245 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC. Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review. Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282 [TBL] [Abstract][Full Text] [Related]
4. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels. Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010 [TBL] [Abstract][Full Text] [Related]
5. Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases. Rohan Z; Smetakova M; Kukal J; Rusina R; Matej R BMC Neurol; 2015 Mar; 15():50. PubMed ID: 25886404 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Stoeck K; Sanchez-Juan P; Gawinecka J; Green A; Ladogana A; Pocchiari M; Sanchez-Valle R; Mitrova E; Sklaviadis T; Kulczycki J; Slivarichova D; Saiz A; Calero M; Knight R; Aguzzi A; Laplanche JL; Peoc'h K; Schelzke G; Karch A; van Duijn CM; Zerr I Brain; 2012 Oct; 135(Pt 10):3051-61. PubMed ID: 23012332 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity evaluation of multiple neurodegenerative proteins for Creutzfeldt-Jakob disease diagnosis using a deep-learning approach. Lee SM; Hyeon JW; Kim SJ; Kim H; Noh R; Kim S; Lee YS; Kim SY Prion; 2019 Jan; 13(1):141-150. PubMed ID: 31306078 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3. Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Goebel S; Waniek K; Lachmann I; Zerr I J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333 [TBL] [Abstract][Full Text] [Related]
10. [New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis]. Zetterberg H; Hammarin AL; Nilsson P; Andersson E; Lind B; Blennow K Lakartidningen; 2005 Mar 21-Apr 3; 102(12-13):956-8, 960-1. PubMed ID: 15887642 [TBL] [Abstract][Full Text] [Related]
11. High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease. Matsui Y; Satoh K; Miyazaki T; Shirabe S; Atarashi R; Mutsukura K; Satoh A; Kataoka Y; Nishida N BMC Neurol; 2011 Oct; 11():120. PubMed ID: 21970675 [TBL] [Abstract][Full Text] [Related]
12. Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease. Wang GR; Gao C; Shi Q; Zhou W; Chen JM; Dong CF; Shi S; Wang X; Wei Y; Jiang HY; Han J; Dong XP Am J Med Sci; 2010 Oct; 340(4):291-5. PubMed ID: 20881758 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease. Blennow K; Johansson A; Zetterberg H Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298 [TBL] [Abstract][Full Text] [Related]
14. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease. Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868 [TBL] [Abstract][Full Text] [Related]
15. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay. Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients. Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113 [TBL] [Abstract][Full Text] [Related]
17. Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt-Jakob disease in clinical practice. Fayolle M; Lehmann S; Delaby C J Neural Transm (Vienna); 2022 Feb; 129(2):133-139. PubMed ID: 35041062 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants. Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease? Humpel C; Benke T Pharmacology; 2017; 100(5-6):243-245. PubMed ID: 28743115 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. Zanusso G; Fiorini M; Ferrari S; Gajofatto A; Cagnin A; Galassi A; Richelli S; Monaco S Int J Mol Sci; 2011; 12(9):6281-92. PubMed ID: 22016658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]